All Pharma News
price-trendAsk Us
Ziopharm`s new CEO fires half of his workforce in first month

Ziopharm`s new CEO fires half of his workforce in first month
Max Gelman ENDPTS
29 Sep 2021
Share Share
Ziopharm finds new CEO; CFO transition at Lonza to take place in December

Ziopharm finds new CEO; CFO transition at Lonza to take place in December
ENDPTS
03 Sep 2021
Share Share
Ziopharm hires new CEO

Ziopharm hires new CEO
FIERCEBIOTECH
30 Aug 2021
Share Share
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy

Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy
GLOBENEWSWIRE
04 May 2021
Share Share
Kuur Announces Interim Clinical Data Supporting CAR-NKT Cell Therapy

Kuur Announces Interim Clinical Data Supporting CAR-NKT Cell Therapy
BUSINESSWIRE
21 Jan 2021
Share Share
Months after a major rebranding around CAR-NKT cells, Kuur Therapeutic

Months after a major rebranding around CAR-NKT cells, Kuur Therapeutic
Nicole DeFeudis ENDPTS
21 Jan 2021
Share Share
Months after a major rebranding around CAR-NKT cells, Kuur Therapeutics

Months after a major rebranding around CAR-NKT cells, Kuur Therapeutics
Nicole DeFeudis ENDPTS
19 Jan 2021
Share Share
CAR-plus: Irish biotech recruits Kite alum Chris Nowers

CAR-plus: Irish biotech recruits Kite alum Chris Nowers
Amber Tong ENDPTS
19 Oct 2020
Share Share
Kuur Announces Publication of Interim Pha1 Data for CAR-NKT Cell Therapy KUR-501

Kuur Announces Publication of Interim Pha1 Data for CAR-NKT Cell Therapy KUR-501
BUSINESSWIRE
12 Oct 2020
Share Share
Kuur Announces First Patients Dosed with Allogeneic CAR-NKT Cell Therapy

Kuur Announces First Patients Dosed with Allogeneic CAR-NKT Cell Therapy
BUSINESSWIRE
29 Sep 2020
Share Share